Stockscreener 앱 받기
0.89
0.85%
0.0075
시간 외 거래:
.88
-0.01
-1.12%
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia appoints medical tech veteran Guido Neels to board of directors - Investing.com Nigeria
Elutia Completes Sale of BioEnvelope to Boston Scientific - MSN
Applying big data sentiment scoring on Elutia Inc.Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Elutia Appoints Guido J. Neels To Board - citybiz
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - The Manila Times
Elutia Inc. Appoints Guido J. Neels to Board of Directors, Strengthening Leadership in Medical Technology - Quiver Quantitative
Elutia appoints accomplished medtech veteran Guido J. Neels to board of directors - MarketScreener
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors - TradingView
When is the best time to exit Elutia Inc.2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Backtesting results for Elutia Inc. trading strategies2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
What MACD signals say about Elutia Inc.2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Using portfolio simulators with Elutia Inc. includedMarket Growth Review & Detailed Earnings Play Strategies - newser.com
Combining machine learning predictions for Elutia Inc.Layoff News & Risk Controlled Stock Pick Alerts - newser.com
Tools to monitor Elutia Inc. recovery probabilityWatch List & High Accuracy Swing Entry Alerts - newser.com
Medical Device Innovator: Michelle LeRoux Williams - The Business Journals
SWK Holdings announces full repayment of Elutia loan following asset sale - Investing.com Canada
SWK Holdings announces full repayment of Elutia loan following asset sale By Investing.com - Investing.com Nigeria
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
SWK Holdings Announces Full Loan Repayment by Elutia - TipRanks
Elutia Closes BioEnvelope Business Sale To Boston Scientific For $88 Million - citybiz
Elutia announces closing of BioEnvelope business sale to Boston Scientific Corporation - MarketScreener
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - The Manila Times
Elutia Inc. Completes $88 Million Sale of BioEnvelope Business to Focus on NXT-41x Development for Breast Reconstruction - Quiver Quantitative
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Benzinga
$88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market - Stock Titan
Elutia (NASDAQ:ELUT) Stock Price Down 6.3% – Should You Sell? - Defense World
Will a bounce in Elutia Inc. offer an exit2025 Dividend Review & Community Consensus Trade Signals - newser.com
What drives Elutia Inc stock priceStock Valuation Metrics & Superior Capital Trading Plans - earlytimes.in
What analysts say about Elutia Inc stockUtilities Sector Analysis & Superior Trading Portfolio - earlytimes.in
1.83%
자본화:
|
볼륨(24시간):